Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Feb;11(2):e778.
doi: 10.1002/iid3.778.

Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study

Affiliations
Multicenter Study

Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study

Francesca Pennati et al. Immun Inflamm Dis. 2023 Feb.

Abstract

Introduction: Young adults with vertical transmission (VT) of human immunodeficiency virus (HIV) represent a fragile population. This study evaluates factors associated with viro-immunological outcome of these patients.

Methods: We performed a multicenter study including HIV-infected subjects with VT ≥ 18 years old from six Italian clinics. Subjects were observed from birth to death, lost to follow-up, or last visit until December 31, 2019. Condition of "optimal viro-immunological status" (OS) was defined as the simultaneous presence of HIV ribonucleic acid (RNA) < 50 copies/mL, CD4+ > 500 cells/mm3 , and CD4+/CD8+ ratio ≥ 1.

Results: A total of 126 subjects were enrolled. At 18 years of age, 52/126 (44.4%) had HIV-RNA > 50 copies/mL, 47/126 (38.2%) had CD4+ < 500/mm3 , and 78/126 (67.2%) had CD4+/CD8+ < 1; 28 subjects (23.7%) presented in the condition of OS. Having a CD4+/CD8+ ratio ≥ 1 at 18 years of age was related with an increased probability of shift from suboptimal viro-immunological status (SOS) to OS (HR: 7.7, 95% confidence interval [CI]: 4.23-14.04), and a reduced risk of shift from the OS to the SOS (HR: 0.49, 95% CI: 0.26-0.92). Acquired immunodeficiency syndrome (AIDS) diagnosis significantly reduced the probability of shift from a viro-immunological SOS to OS (HR: 0.09, 95% CI: 0.03-0.30). Subjects who had not achieved an OS at 18 years of age had an increased risk of discontinuation of combination antiretroviral therapy (cART, p = .019).

Conclusions: Only a small proportion of subjects with VT of HIV reached the adult age with "OS". Transition to the adult care with a compromised viro-immunological condition represents a negative driver for future optimal infection control, with a higher risk of discontinuation of cART and a reduced probability to improve the immunological status later in the years.

Keywords: HIV; antiretroviral therapy; discontinuation; vertical transmission; viro-immunological effectiveness.

PubMed Disclaimer

Conflict of interest statement

Emanuele Focà received speakers' honoraria, research grants, and advisory board fees from Viiv Healthcare, Janssen‐Cilag, Gilead Sciences, and Merck Sharp & Dohme. The remaining authors declare no conflict of interest.

Similar articles

References

    1. Global HIV Programme. 2021. Accessed January 18, 2023. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/s...
    1. Fact sheet—Latest global and regional statistics on the status of the AIDS epidemic. Enhanced Reader.
    1. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV‐1 infection. JAMA. 2000;284(2):190‐197. - PubMed
    1. Cuéllar‐Flores I, Saínz T, Velo C, et al. Impact of HIV on the health‐related quality of life in youth with perinatally acquired HIV. World J Pediatr. 2019;15(5):492‐498. - PubMed
    1. Mellins CA, Tassiopoulos K, Malee K, et al. Behavioral health risks in perinatally HIV‐exposed youth: co‐occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS. 2011;25(7):413‐422. - PMC - PubMed

Publication types